| Index | S&P 500 | P/E | 87.62 | EPS (ttm) | 1.08 | Insider Own | 1.32% | Shs Outstand | 255.15M | Perf Week | -1.11% |
| Market Cap | 24.14B | Forward P/E | 24.10 | EPS next Y | 3.93 | Insider Trans | 7.63% | Shs Float | 254.45M | Perf Month | 10.71% |
| Enterprise Value | 29.74B | PEG | 6.62 | EPS next Q | 0.81 | Short Float | 6.48% | Perf Quarter | 4.67% | ||
| Income | 290.00M | P/S | 2.42 | EPS this Y | -21.11% | Short Ratio | 9.66 | Perf Half Y | 30.25% | ||
| Sales | 9.98B | P/B | 1.72 | EPS next Y | 17.20% | ROA | 1.15% | Short Interest | 16.48M | Perf YTD | 36.79% |
| Book/sh | 54.91 | P/C | 42.43 | EPS next 5Y | 13.24% | ROE | 2.05% | 52W High | 95.27 -3.24% | Perf Year | 46.39% |
| Cash/sh | 2.23 | P/FCF | 45.05 | EPS past 3/5Y | — | ROIC | 2.79% | 52W Low | 61.30 50.38% | Perf 3Y | 35.86% |
| Dividend Est. | 1.60 (1.74%) | EV/EBITDA | 20.01 | Sales past 3/5Y | -4.34% 16.46% | Gross Margin | 37.52% | Volatility | 2.64% 2.08% | Perf 5Y | -37.75% |
| Dividend TTM | 1.60 (1.74%) | EV/Sales | 2.98 | EPS Y/Y TTM | — | Oper. Margin | 7.78% | ATR (14) | 2.06 | Perf 10Y | -29.37% |
| Dividend Ex-Date | Dec 18, 2026 | Quick Ratio | 1.72 | Sales Y/Y TTM | -11.72% | Profit Margin | 2.91% | RSI (14) | 58.59 | Recom | 2.29 |
| Dividend Gr. 3/5Y | -20.63% -12.05% | Current Ratio | 2.06 | EPS Q/Q | -28.70% | SMA20 | 2.06% | Beta | 0.87 | Target Price | 98.14 |
| Payout | 141.03% | Debt/Eq | 0.44 | Sales Q/Q | -29.31% | SMA50 | 5.74% | Rel Volume | 1.63 | Prev Close | 94.63 |
| Employees | 21,500 | LT Debt/Eq | 0.37 | Earnings | Feb 10 | SMA200 | 17.04% | Avg Volume | 1.80M | Price | 92.18 |
| IPO Date | Dec 17, 1974 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -23.04% -25.45% | Net Debt/EBITDA | 3.76 | Volume | 2,948,991 | Change | -2.59% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-22-26 | Reiterated | Oppenheimer | Outperform | $95 → $108 |
| Oct-16-26 | Reiterated | Barclays | Overweight | $96 → $105 |
| Oct-07-26 | Reiterated | Argus Research | Buy | $80 → $95 |
| Aug-07-26 | Reiterated | Barclays | Overweight | $90 → $96 |
| Aug-06-26 | Reiterated | Robert W. Baird | $90 → $100 | |
| Aug-06-26 | Reiterated | Oppenheimer | Outperform | $90 → $95 |
| Aug-06-26 | Reiterated | Vertical Research | Buy | $93 |
| Aug-06-26 | Reiterated | UBS | Neutral | $75 → $91 |
| Jul-01-26 | Reiterated | Morgan Stanley | Overweight | $93 → $95 |
| May-07-26 | Reiterated | Oppenheimer | Outperform | $97 → $90 |
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9,978 | 10,890 | 11,484 | 11,479 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 6,234 | 6,952 | 7,360 | 7,798 | — | — | — | — | — | |
| Gross Profit | 3,744 | 3,938 | 4,124 | 3,681 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,754 | 1,834 | 1,995 | 1,787 | — | — | — | — | — | |
| Research and Development | 684 | 694 | 671 | 636 | — | — | — | — | — | |
| Other Operating Expense | 530 | 568 | 692 | 3,368 | — | — | — | — | — | |
| Operating Income | 776 | 842 | 766 | -2,110 | — | — | — | — | — | |
| Interest Expense | 187 | 229 | 305 | 380 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -238 | -1,025 | -183 | -28 | — | — | — | — | — | |
| Net Income Before Taxes | 351 | -412 | 278 | -2,518 | — | — | — | — | — | |
| Income Taxes | 76 | -53 | 31 | 45 | — | — | — | — | — | |
| Consolidated Net Income | 290 | -361 | 243 | -2,565 | — | — | — | — | — | |
| Net Income From Continuing Operations | 275 | -359 | 247 | -2,563 | — | — | — | — | — | |
| Net Income | 290 | -361 | 243 | -2,565 | — | — | — | — | — | |
| EPS (Recurring) | 1.09 | -1.46 | 0.95 | -10.06 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.09 | -1.46 | 0.95 | -10.06 | — | — | — | — | — | |
| EPS (Diluted) | 1.08 | -1.46 | 0.95 | -10.06 | — | — | — | — | — | |
| EBITDA | 1,486 | 779 | 1,598 | -996 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 85.35 | — | 89.00 | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.37 | 1.58 | 1.88 | 1.80 | — | — | — | — | — | |
| Gross Margin | 37.52 | 36.16 | 35.91 | 32.07 | — | — | — | — | — | |
| Operating Margin | 7.78 | 7.73 | 6.67 | -18.38 | — | — | — | — | — | |
| Net Margin | 2.91 | -3.31 | 2.12 | -22.35 | — | — | — | — | — | |
| Shares Outstanding | 256 | 256 | 256 | 255 | — | — | — | — | — | |
| Market Capitalization | 23,598 | 17,252 | 21,645 | 20,647 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Teles de Mendonca Ana Paula | President, Scent | Aug 17 '26 | Sale | 83.19 | 5,718 | 475,692 | 0 | Aug 19 |
| Birenkrant Marc | Controller & CAO | Aug 07 '26 | Sale | 85.00 | 1,000 | 85,000 | 3,446 | Aug 10 |
| DeVeau Michael | EVP, CFO | Aug 06 '26 | Sale | 85.55 | 8,825 | 754,970 | 5,199 | Aug 07 |
| FRIBOURG PAUL J | Director | Jun 01 '26 | Buy | 74.29 | 273,500 | 20,317,854 | 2,682,730 | Jun 02 |
| Borg Deborah | EVP, Chief Ppl&Culture Officer | May 04 '26 | Option Exercise | 0.00 | 1,768 | 0 | 38,638 | May 06 |
| Birenkrant Marc | Controller & CAO | May 04 '26 | Option Exercise | 0.00 | 389 | 0 | 4,587 | May 06 |
| Teles de Mendonca Ana Paula | President, Scent | May 04 '26 | Option Exercise | 0.00 | 708 | 0 | 6,080 | May 06 |
| Finzel Ralf | EVP, Global Operations Officer | May 04 '26 | Option Exercise | 0.00 | 1,326 | 0 | 18,355 | May 06 |
| DeVeau Michael | EVP, CFO | May 04 '26 | Option Exercise | 0.00 | 884 | 0 | 14,476 | May 06 |
| O'Byrne Kevin | Director | May 01 '26 | Option Exercise | 0.00 | 4,282 | 0 | 18,728 | May 04 |
| Khan Mehmood | Director | May 01 '26 | Option Exercise | 0.00 | 2,569 | 0 | 7,173 | May 04 |
| Mulligan Richard | Director | May 01 '26 | Option Exercise | 0.00 | 1,712 | 0 | 1,712 | May 04 |
| ICAHN BRETT | Director | May 01 '26 | Option Exercise | 0.00 | 1,712 | 0 | 34,712 | May 04 |
| Drosos Virginia | Director | May 01 '26 | Option Exercise | 0.00 | 2,335 | 0 | 2,434 | May 04 |
| Teles de Mendonca Ana Paula | President, Scent | May 01 '26 | Option Exercise | 0.00 | 1,587 | 0 | 5,997 | May 04 |